hepatitis B

Chronic Hepatitis B Infections in Europe on the Rise Since 2008

In 2017, the considerable high rate of 26,907 reported hepatitis B infections particularly chronic cases, in combination with the diversity in stated transmission routes across Europe suggested that countries need to maintain and strengthen local hepatitis prevention and control programs

‘Green Revolution’ in RNAi Tools and Therapeutics

This work does not only offer an affordable treatment strategy for chronic hepatitis B patients in developing countries but also reduces the required dose of RNAi drugs to minimize the potential side effects of RNAi therapy and allow the administration for a relatively long period or in conjunction with other antiviral drugs

Recommended Stories

Real Time Analytics